SEC Form 4 · accession 0001209191-17-039812
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Taylor Horn
Officer — Chief Medical Officer
Period of report
Jun 13, 2017
Accepted (ET)
Jun 14, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2017 | M | 10,000 | $2.03 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.03 | Jun 13, 2017 | M | 10,000 | D | — | Jan 2, 2021 | Common Stock | 10,000 | 47,689 | D |
Explanation of responses
- F1This option is fully vested.